你即將離開本站

並前往https://www.urotoday.com/conference-highlights/asco-2020/asco-2020-kidney-cancer/121883-asco-2020-phase-ii-trial-of-lenvatinib-plus-pembrolizumab-for-disease-progression-after-pd-1-pd-l1-immune-checkpoint-inhibitor-in-metastatic-clear-cell-renal-cell-carcinoma.html

ASCO 2020: Phase II trial of Lenvatinib plus Pembrolizumab ...

This phase II trial provides encouraging data on lenvatinib + pembrolizumab as a second-line option for patients with metastatic RCC who ...

確定！ 回上一頁

查詢 「Lenvatinib」的人也找了：

  1. lenvatinib機轉
    2.
  2. lenvatinib價格
    3.
  3. lenvatinib健保價
    4.
  4. lenvatinib仿單
    5.
  5. lenvatinib健保
    6.
  6. lenvatinib藥廠
    7.
  7. lenvatinib副作用
    8.
  8. lenvatinib標靶
    9.